ReconTop Stories

Stryker Launches New Gamma4 Hip Fracture Nailing System

New System to Strengthen the Gamma Legacy and Streamline Procedure Workflows

KALAMAZOO, Mich.–(BUSINESS WIRE)–Stryker (NYSE:SYK) has launched the Gamma4 System, strengthening the product’s 30-year legacy of continuous innovation and clinical history. The newest Gamma System will provide surgeons with the next generation of Stryker’s intramedullary nailing system.

“Since 2004, the Gamma3 System has been the proven work horse of our Trauma business,” said Eric Tamweber, Vice President and General Manager, Stryker’s Trauma business unit. “But we aren’t proven because we have a legacy; we have a legacy because we are proven. That’s why we’re so excited to introduce Gamma4—an enhanced, modern product that is designed to fulfill our customers’ hip fracture needs.1

The Gamma4 System is indicated for the treatment of stable and unstable fractures as well as for stabilization of bones and correction of bone deformities in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur (including osteoporotic and osteopenic bone). The system features:

  • Precision Pin: With the Precision Pin™, the potential for skiving is reduced by 66% compared to a standard ∅3.2 k-wire.2
  • A redefined nail design: The SOMA-designed nail features length-dependent RoC, a shortened proximal body and a chamfered distal tip with a pre-inserted set screw.
  • An integrated instrument platform: The streamlined portfolio of all Stryker nails now works off the existing IMN Basic set.

“Our design team spent the last decade working to understand how we could enhance the Gamma System based on surgeon experience and feedback,” said James Maxey, M.D., orthopaedic surgeon and a design surgeon for Gamma4. “Our goal when designing the Gamma4 system was to make it easier for the surgeon—and better for the patient. Being one of the most commonly used devices to repair a hip fracture, I’m confident that we met our goal of reshaping patient hip fracture care for many years to come.”

“The Gamma4 System features the Precision Pin™, which allows me to control the placement of the Lag Screw while having familiar instrumentation to the T2 Alpha System,” said David Forsh, M.D., an orthopaedic surgeon at Mount Sinai Hospital in New York. “The instrumentation is sleek, the nail design and geometry have been enhanced and the nail facilitates the ease of insertion, which is one of the biggest benefits I have experienced firsthand in the operating room.”

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at


  1. Regling, Matthias. EPS Final Report (D0000205786), Stryker Trauma Kiel, Germany
  2. Internal test report D0000099352

Drs. Maxey and Forsh are paid consultants of Stryker Orthopaedics. The opinions expressed by Drs. Maxey and Forsh are those of Drs. Maxey and Forsh and not necessarily those of Stryker. Individual experiences may vary.

A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.

The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.

G4-LT-1 07-2022

Andrea Sampson
President/CEO, Sampson Public Relations Group

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button